| Date | Title | Description |
| 20.10.2020 | New management at life sciences start-ups | |
| 20.10.2020 | New management at life sciences start-ups | Aktiia SA is a Swiss-US start-up developing an accurate, wrist-worn optical blood pressure monitor that can automatically take measurements 24/7. As the company rapidly approaches the commercial launch of its product, Aktiia welcomed Michae... |
| 22.09.2020 | Polyneuron Raises Additional CHF 14M; Expands Series A to CHF 36.5M | Polyneuron Pharmaceuticals AG, a Basel, Switzerland-based clinical stage developer of a new class of antigen-specific polymers for the treatment of patients with serious autoimmune diseases, raised a CHF 14m extension of the Series A, bring... |
| 16.09.2020 | Polyneuron extends Series A to CHF 36.5 million by raising an additional CHF 14 million to advance its lead product candidate | Polyneuron was a Venture Kick winner and a Venture Leader in 2015 and was one of the TOP 100 Swiss startups for five consecutive years (2015-2019). Polyneuron is also among the 25 most promising scale-ups 2020.
The biotech startup, a clinic... |
| 16.09.2020 | Polyneuron Extends Series A to CHF36.5 Million | |
| 16.09.2020 | Polyneuron extends Series A to CHF 36.5 million by raising an additional CHF 14 million to advance its lead product candidate | Polyneuron extends Series A to CHF 36.5 million by raising an additional CHF 14 million to advance its lead product candidate 16.09.2020 09:30, Isabelle Mitchell linkedIn facebook twitter instagram youtube -->
Basel-based Polyneuron will... |
| 16.09.2020 | Polyneuron Extends Series A to CHF36.5 Million | Polyneuron will use the proceeds to advance its lead product candidate PN-1007, a potential treatment for anti-MAG neuropathy, a serious nervous system disease with a high unmet medical need, through Phase I/IIa clinical development. Clinic... |
| 12.06.2020 | FDA approval paves the way for two Swiss startups | |
| 12.06.2020 | FDA approval paves the way for two Swiss startups | GTX medical developed Go-2 system to promote the recovery of leg motor functions and neurological control in adults with spinal cord injuries (SCI) and paralysis. Specifically, the device is designed to improve the reconnection of the brain... |
| 07.04.2020 | Polyneuron submits clinical trial application | |
| 07.04.2020 | Polyneuron submits clinical trial application | Basel-based Polyneuron Pharmaceuticals is pioneering a novel therapeutic approach for the effective and safe treatment of antibody-mediated autoimmune diseases of the nervous system where a pathological role of anti-carbohydrate autoantibod... |
| 24.01.2020 | Venture Kick to inject 5 million Swiss francs in 80 projects | |
| 24.01.2020 | Venture Kick to inject 5 million Swiss francs in 80 projects | Venture Kick is a philanthropic initiative that provides up to CHF 150,000 in seed funding to Swiss startups in addition to a well-structured entrepreneurial path towards building a winning business. Startups pitch to expert juries at three... |
| 23.09.2019 | The next big step with experienced personalities | |
| 29.03.2019 | Term Sheet — Friday, March 29 | THE SMALL IPO IS DEAD
I’ll never forget Lyft president John Zimmer’s comment at Fortune’s Brainstorm Tech conference in Aspen last year: “Four or five years ago, we woke up one day and Uber had 30 times the amount of cash as us. Thirty time... |
| 28.03.2019 | Daily funding roundup - March 28th, 2019 | BillionToOne raised $15M; Polyneuron Pharmaceuticals secured $22.6M;Prevail Therapeutics lands $50M
Artiphon: Artiphon is empowering a new generation to explore music-making with smart instruments and adaptive software. Artiphon has raised ... |
| 28.03.2019 | Polyneuron Raises CHF22.5 M for Autoimune Diseases | |
| 28.03.2019 | Polyneuron Raises CHF 22.5m to Trial Autoimmune Disease Drug | The University of Basel spin-off, which is developing a new class of treatment for anti-MAG neuropathy and other rare-disorders, won Venture Kick and Venture Leaders in 2015. In our interview Polyneuron's CEO Ruben Herrendorff explains how ... |
| 28.03.2019 | Polyneuron Raises CHF22.5M in Series A Funding | Polyneuron Pharmaceuticals AG, a Basel, Switzerland-based developer of a new class of biodegradable glycopolymers for the treatment of autoimmune diseases, closed a CHF22.5m Series A financing.
The round was led by Sofinnova Partners and co... |
| 22.05.2018 | Polyneuron successfully closed CHF 3.1 million in financing | Polyneuron successfully closed CHF 3.1 million in financing 22.05.2018 09:00, Charlotte Pichon linkedIn facebook twitter instagram youtube -->
The Venture Leaders alumnus and 2015-2017 TOP 100 Swiss Startups completed a CHF 3.1 million i... |
| 14.05.2018 | Polyneuron completes CHF3 million seed financing | |
| 14.05.2018 | Polyneuron Pharmaceuticals Completes CHF3.1M in Seed Financing | Polyneuron Pharmaceuticals AG, a Basel, Switzerland-based developer of a new class of biodegradable glycopolymer treatments for autoimmune diseases, closed a CHF3.1m financing, following the receipt of a second tranche.
The financing was le... |
| 31.01.2018 | BaseLaunch selektiert sechs Startups für zweite Förderphase | |
| 18.09.2017 | BaseLaunch startups: From gene therapies to digital measurement | |
| 24.07.2017 | Polyneuron has obtained the orphan drug designation from the EMA for PN-1007 | Anti-MAG neuropathy is a severe and chronically debilitating autoimmune disease of the peripheral nervous system affecting approximately 70’000 patients worldwide. Patients with anti-MAG neuropathy suffer from sensory loss in their arms and... |
| 24.07.2017 | Polyneuron has obtained the orphan drug designation from the EMA for PN-1007 | Polyneuron has obtained the orphan drug designation from the EMA for PN-1007 24.07.2017 10:30, Anne-Lea Marte linkedIn facebook twitter instagram youtube -->
The venture leader, TOP 100 startup 2015/2016 and Venture Kick alumnus Polyneur... |
| 20.07.2017 | Polyneuron Pharmaceuticals receives EMA orphan drug designation | |
| 02.03.2017 | Biotech startups receive the CTI startup label | |
| 01.09.2016 | Ten IMD Startup Competition winners travel to the Silicon Valley | |
| 30.05.2016 | Polyneuron awarded at The Brain Forum 2016 | |
| 12.05.2016 | CHF 3 million to fight autoimmune disease | CHF 3 million to fight autoimmune disease 12.05.2016 12:00, Tina Lohfing linkedIn facebook twitter instagram youtube -->
Polyneuron a spin-off of the University of Basel is developing a compound for the treatment of autoimmune disorders.... |
| 12.05.2016 | CHF 3 million to fight autoimmune disease | The funding will be used to progress the further development of the company’s drug discovery platform for autoimmune diseases and the preclinical development of its lead candidate calles PN-1007 for the treatment of anti-MAG neuropathy, a d... |
| 12.05.2016 | Polyneuron Pharmaceuticals closes CHF 3 Million seed financing round | |
| 15.12.2015 | IMD announces the 25 startup competition winners of 2016 | Created in 1999, the IMD Award competition provides a unique opportunity for regional start-ups to benefit from the help and insights from participants in the IMD MBA and the Executive MBA programs - highly talented, experienced and motivat... |
| 14.12.2015 | IMD announces the 25 startup competition winners | |
| 17.09.2015 | Die 100 besten Startups der Schweiz gekürt | |
| 17.09.2015 | TOP100 2015: Les 100 start-up qui secouent la Suisse | |
| 15.07.2015 | Science4Life Venture Cup 2015: Basler Start-up ausgezeichnet | |
| 02.06.2015 | A new era in treatments of autoimmune diseases and clinical trials: Two spin-offs kicked by CHF 130.000 each | A new era in treatments of autoimmune diseases and clinical trials: Two spin-offs kicked by CHF 130.000 each 02.06.2015 14:00, Nicolas Bopp linkedIn facebook twitter instagram youtube -->
Two great biotech startups, Polyneuron Pharmaceut... |
| 02.06.2015 | A new era in treatments of autoimmune diseases and clinical trials: Two spin-offs kicked by CHF 130.000 each | When a person is affected by an infection, the body creates specialized immune cellsand antibodies that attack foreign infectious agents. In the case of autoimmune diseases such as multiple sclerosis, rheumatoid arthritis or Crohn's disease... |
| 02.06.2015 | Polyneuron wins third round of venture kick | |
| 25.03.2015 | The Swiss National Startup Team ready to conquer the USA | 20 Swiss startups ready to take over the US market
“I am really happy to be part of the adventure”, says Deepak Tewari, CEO of Privately, one of the 20 winners of the program. He will be able to bring his “right-to-be-forgotten” privacy sol... |
| 25.03.2015 | The “Swiss National Startup Team” ready to conquer the USA | |
| 25.03.2015 | The Swiss National Startup Team ready to conquer the USA | The Swiss National Startup Team ready to conquer the USA 25.03.2015 14:00, Lara Rossi linkedIn facebook twitter instagram youtube -->
The winners of the venture leaders USA 2015 prize have been chosen after a highly competitive selection... |
